Sugammadex Efficacy and Safety for Reversal of Pipecuronium-induced Neuromuscular Blockade

Clinical trial NCT01424488 · UNKNOWN

Trial details

NCT number

NCT01424488

Sponsor

Central Clinical Hospital #1 of LLC Russian Railways

Status

UNKNOWN

Phase

Phase 4

Study type

INTERVENTIONAL

Start date

2011-09-01

Primary completion

2012-02-01

Enrollment

42

View on ClinicalTrials.gov